Paloma Partners’s IDENIX PHARMACEUTICALS INC IDIX Stock Holding History

Paloma Partners’s Portfolio IDIX Stock Details IDIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-10,000	Closed	-$241K	–	1577
2014 Q2	$241K	Buy	+10,000	New	+$104K	0.01%	880

Paloma Partners's IDIX Position: Q3 2014 in Review

Paloma Partners sold out of IDENIX PHARMACEUTICALS INC (IDIX) in Q3 2014, closing a stake of 10,000 shares — an estimated $241K sold.

Paloma Partners first reported a position in IDIX in Q2 2014 and held it in 1 quarter. The position peaked at $241K in Q2 2014. 0 funds tracked by Wall St. Rank hold IDIX as of Q3 2014.

Paloma Partners reported no remaining IDENIX PHARMACEUTICALS INC position as of Q3 2014 after selling out during the quarter.
Paloma Partners sold 10,000 IDENIX PHARMACEUTICALS INC shares in Q3 2014, an estimated $241K.
Paloma Partners first reported a position in IDENIX PHARMACEUTICALS INC in Q2 2014 and held it in 1 quarter.
Paloma Partners's IDENIX PHARMACEUTICALS INC position peaked at $241K in Q2 2014.
0 funds tracked by Wall St. Rank held IDENIX PHARMACEUTICALS INC as of Q3 2014.

Based on Paloma Partners's 13F filing for Q3 2014, filed 14 Nov 2014.